Table of Contents
Volume 32, Issue 3 (May 15, 2023)
If you are a subscriber, click HERE.
Articles
IBO’s 2022 Executive Compensation Review
ABRF 2023 Meeting: Single-Cell Research and Technology Development
PerkinElmer Becomes Revvity
Executive Briefing
The latest on Ilumina, Bruker, Biosynth and more
Financial
First Quarter Results: Danaher, Illumina, Sartorius, Thermo Fisher Scientific and Waters
Market Profile
Laser Capture Microdissection
Industry Watch
Pharma and Government: FDA Seeks Feedback on Nitrosamines
Chemicals: The Top 50 Companies
Life Science: Lab Real Estate Inventory Increases
Region Watch
Mexico: Government Bill Affects Science
South Korea: New Chip Plan
China: ATMP Submissions
News
Broad-Based Companies
MS, LC/MS & GC/MS
Informatics
Materials Characterization
Bottom Line
Latest financial results
Getting to Know the Association of Biomolecular Resource Facilities (ABRF)
The Association of Biomolecular Resource Facilities (ABRF) will hold its Annual Meeting May 7–10, 2023 in Boston, Massachusetts. ABRF is a membership organization that brings together Core facilities across the US and supports more than 2,400 members at over 400 institutions including organizations in government, academia, research, industry and commercial settings. Over 50% of members […]
Synthace: Digitalizing Experiment-Planning
Digitalization has become an aim of many scientific labs. One way to do so is by transforming written information or even information retained in one’s memory into a digital format. Although scientific data produced by instrumentation or informatics analysis is usually automatically digitally recorded, how an experiment is planned and optimized is one of many […]
Dividends as an Indicator for Laboratory Tool Industry Companies in 2022
In 2022, uncertainty was the dominant tone for the US stock market as investor sentiment waned due to geopolitical conflicts, high inflation, mixed macroeconomic data, recession fears and more. As a result, major stock indexes such as the Dow Jones Industrial Average, NASDAQ and S&P 500 posted declines for the year. In addition, many industries […]
Improving Drug Development: Molecular Devices and Cellesce Aim to Advance the Use of Organoids
Molecular Devices, a life science tools company, has long been associated with its plate reader, imaging technology and software. Now, the company is making significant investments in organoid technologies, which it views as the future of drug discovery and development. These investments include the acquisition of organoid provider Cellesce, a developer and manufacturer of patient-derived […]
Danaher Investor Day 2022 Showcases Big Announcements and Focuses on Cytiva
Danaher made major announcements at its September 15, 2022 investor day. A $29.5 billion company, Danaher spans three business segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The segments encompass over 20 operating companies consisting of well-established brands and are known for a robust M&A track record. The first major announcement was that Danaher […]